Quest Diagnostics News
Landmark Drug Testing Index™ analysis from Quest Diagnostics coincides with passage of the Drug-Free Workplace Act 25 years ago todayRead More
Also Releases Results from National Harris Survey Revealing Widespread Confusion about BRCA TestingRead More
What's New for ExamOne in 2014? 11-21-2013
We continue to prepare for our pilot phase of the ExamOne Portal. This new web application will replace our existing ordering websites and create a unified, next-generation experience for our client users to view orders, statuses, and results. As we continue to enhance the ExamOne Portal, additional functionality will be incorporated to facilitate the management of all requirements in a single location.Read More
Seventy-two Percent (72 percent) of Adult Women in the U.S. Have Never Heard of BRCA Testing, yet 58 Percent Would Want to Know if They Carried High-Risk Gene MutationsRead More
In both the United States and Canada we are experiencing a diabetes epidemic which can result in vascular (both micro and macro) complications. If not diagnosed early and treated, these complications can lead to renal failure, cardiovascular disease, amputations, blindness and even early death.
One of the important biomarkers for kidney (nephropathy) as well as vascular disease are the “little proteins” called microalbumin. Microalbuminuria is really a misnomer. The albumin found in the urine is not “little” in size, but it is often found in small amounts that cannot be detected by a standard urine dipstick, thus obtaining its name – microalbuminuria.Read More